Search

Author/Creator Kang, Ciming

1. A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys. Issue 1 (4th July 2017)

Authors:
Kang, Ciming; Xia, Lin; Chen, Yuanzhi; Zhang, Tianying; Wang, Yiwen; Zhou, Bing; You, Min; Yuan, Quan; Tzeng, Chi-Meng; An, Zhiqiang; Luo, Wenxin; Xia, Ningshao
Journal:
Protein & cell
Issue:
Volume 9:Issue 1(2018)
Page Start:
130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Novel monkey mAbs induced by a therapeutic vaccine targeting the hepatitis B surface antigen effectively suppress hepatitis B virus in mice. (29th September 2021)

Authors:
Chen, Yuanzhi; Xiang, Xinchu; Qi, Ruoyao; Wang, Yiwen; Huang, Yang; You, Min; Xian, Yangfei; Wu, Yangtao; Fu, Rao; Kang, Ciming; Tang, Jixian; Yu, Hai; Zhang, Tianying; Yuan, Quan; Luo, Wenxin; Xia, Ningshao
Journal:
Antibody therapeutics
Issue:
Volume 4:Number 4(2021)
Page Start:
197
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search